Smoking Cessation in Lung Cancer Screening: The Latest Randomized Controlled Trial Evidence

… the US Veterans Health Administration (VA). 5 , 7  This research sought to determine the key components … the trials were conducted in 76 clinics with over 5,700 research participants nationwide.   SCALE Collaboration … support was delivered to clinical providers; of note, the research team did not intervene directly with patients. 20 …

Regulating Artificial Intelligence

… regulate the use of artificial intelligence in clinical research? How likely is it that AI could lead us to erroneous … data-driven tools. ILCN:  Another potential use for AI in research could be evaluating disease burden. To what extent do … Singh:  FDA recognizes the interest and potential for AI research tools to aid in disease evaluation, such as with …

Research Supports Use of Lung Nodule Programs to Improve Early Detection Efforts

… for lung cancer screening based on existing guidelines. … Research Supports Use of Lung Nodule Programs to Improve Early …

Narrow Focus Allows Pragmatica-Lung Trial to Minimize Eligibility Criteria, Significantly Reduce Data Collection, Researcher Says

… Criteria, Significantly Reduce Data Collection, Researcher Says … Erin Jungmeyer …

First Presidential Symposium to Explore Practice-Changing Research in Lung Cancer Screening, Immune Oncology

… First Presidential Symposium to Explore Practice-Changing Research in Lung Cancer Screening, Immune Oncology …

Funding Opportunities for Innovative Multidisciplinary Cancer Research Teams

… Opportunities for Innovative Multidisciplinary Cancer Research Teams …

Ongoing Research Looks at Optimizing Lung Cancer Screening Programs

… false positives against delayed diagnosis. … Ongoing Research Looks at Optimizing Lung Cancer Screening Programs … …

US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective

… of care and limited resources to review applications, researchers say they support the agency’s decision not to …

Pragmatic Approach to Trial Design Born from Lung-MAP Substudy

… new pragmatic approach to trial design can streamline research and ultimately benefit patients. … Pragmatic Approach …

Real-World Data from Taiwan Shows Stage Shift Has Improved Lung Cancer Survival Rates

… Researchers say increased screening of at-risk populations, …

US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR

… In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited …